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background: L-selectin ligands, localized to the luminal epithelium at the time of implantation, may support the early stages of blas-
tocyst attachment. We have assessed the expression of two L-selectin ligands, deﬁned by MECA-79 and HECA-452 monoclonal antibodies,
and the sulfotransferase GlcNAc6ST-2, involved in generation of L-selectin ligand epitopes, in the secretory phase of the endometrium from
fertile and infertile patients.
methods: Endometrial samples were obtained from 33 fertile, 26 PCOS, 25 endometriosis and 33 patients diagnosed with unexplained
infertility. L-selectin ligands and GlcNAc6ST-2 expression was assessed by immunohistochemistry and immunoblotting.
results: Immunohistochemical staining of uterine epithelium, from fertile and infertile women, demonstrated differential expression of
MECA-79 and HECA-452 epitopes. In fertile women in the secretory phase MECA-79 was more strongly expressed, particularly on the
lumen, than in infertile women. HECA-452 staining was signiﬁcantly stronger in the glands in PCOS and endometriosis patients than in
fertile women. GlcNAc6ST-2 expression was reduced in infertile patients, correlating with MECA-79 expression.
conclusions: This study demonstrated signiﬁcant differences in expression of L-selectin ligands between fertile and infertile women in
natural cycles, and could contribute to patient assessment prior to initiating fertility treatment.
Key words: MECA-79 / HECA-452 / L-selectin ligands / endometrium / fertility
Introduction
Preparation of the endometrium for implantation is dependent on
adequate hormonal stimulation and the presence of appropriate
mediators at the endometrium–blastocyst interface. In humans,
there is a distinct ‘window of implantation’ during the mid-luteal
phase when the endometrium demonstrates maximal receptivity for
embryo implantation (Carson et al., 2000). The implantation
process of apposition, adhesion and invasion bears some similarity
to leukocyte transmigration across the blood vessel wall. Numerous
studies have shown that the initial interaction between leucocytes
and the vascular endothelial cell surface is mediated by selectin
adhesion systems (Alon and Feigelson, 2002; Rosen, 2004).
Selectins are a group of cell adhesion molecules that include P-selec-
tin (CD62P), L-selectin (CD62L) and E-selectin (CD62E). All selectins
bind with low afﬁnity to glycans containing a2,3-linked sialic acid and
a1,3-linked fucose residues such as the Sialyl Lewis x (sLe
x)d e t e r m i -
nant (NeuAca2,3Galb1,3[Fuca1,3]GlcNAcb1-R). In addition, only P-
and L-selectin bind more strongly to sulfated fucosylated glycoconju-
gates (Tangemann et al., 1999). Carbohydrate ligands that bind L-
selectin are localized on human endometrial luminal epithelium at the
time of implantation, whereas the trophoectoderm expresses L-selectin
strongly after hatching (Genbacev et al., 2003). Cytotrophoblast pro-
genitors, cytotrophoblasts in cell columns and invasive cytotrophoblast
react strongly with L-selectin antibodies. Trophoblast lineages use
L-selectin to bind to uterine epithelial oligosaccharide ligands; when
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thelium is impaired (Genbacev et al., 2003; Minas et al., 2005). This
raises the possibility that selectin ligands expressed on the apical
surface of the uterine epithelium support early stages of blastocyst
attachment. Hatched blastocysts express L-selectin, and this molecule
mediates its attachment to the luminal epithelial surface via carbo-
hydrate ligands. The expression of L-selectin ligands has been described
in the human endometrium during natural and oocyte donor cycles
(Ben-Nun et al., 1992; Lai et al., 2005).
Lai and colleagues demonstrated signiﬁcant differences in L-selectin
ligand expression in luminal epithelium during the proliferative, early
secretory and mid-secretory phase. The expression of L-selectin
ligand was greatest from the periovulatory interval through mid-
secretory phase. In the glandular epithelium the expression of
L-selectin ligands was greatest in the mid-secretory phase (Lai et al.,
2005). Immunolocalization studies on normal endometrium have
demonstrated that the L-selectin carbohydrate ligand MECA-79 is
up-regulated from the day of ovulation to day 6-post ovulation and
is reduced throughout the follicular phase or in anovulatory cycles
(Genbacev et al., 2003; Lai et al., 2005; Shamonki et al., 2006).
MECA-79 is an antibody that recognizes 6-sulfo sLe
x, a sulfation
dependent determinant on L-selectin ligands that overlaps with the
ligands’ recognition epitope (Pablos et al., 2005). The expression of
GlcNAc6ST-2 (N-acetylglucosamine-6-O-sulfotransferase), a sulfo-
transferase localized in high endothelial venules, is essential for the
elaboration of functional ligands within the lymph node as well as
the generation of the MECA-79 epitope (Hiraoka et al., 1999). The
role of GlcNAc6ST-2 in the generation of L-selectin ligands in lym-
phoid organ has been clearly established in mice genetically deﬁcient
in this enzyme (Hemmerich et al., 2001). The use of GlcNAc6ST-2
speciﬁc antibodies has demonstrated de novo induction of this
enzyme in the high endothelial venules-like vessels and its correlation
with the presence of MECA-79 epitope in several mouse models with
chronic inﬂammation (Yeh et al., 2001; Bistrup et al., 2004).
HECA-452 is an anti-sLe
x mAb requiring both the presence of a2,3
sialylation and a1,3 fucosylation for epitope recognition (Toppila et al.,
1999). Additional analyses have shown HECA-452 up-regulation,
when the endometrium becomes receptive during the window of
implantation (Genbacev et al., 2003).
There is limited evidence on the presence of L-selectin ligands in the
endometrium from women with different pathological conditions that
are associated with infertility. Our hypothesis is that L-selectin ligands
play a signiﬁcant role in the apposition and attachment of the embryo
to the receptive endometrium during implantation. If expression of
L-selectin ligands is an important factor in determining endometrial
receptivity, then alteration in their expression could contribute to
endometrium-related infertility. The objective of this study was there-
fore to evaluate the pattern of distribution and intensity of L-selectin
ligands in the endometrium from both fertile and infertile women
during the window of implantation.
Materials and Methods
Patients
Endometrial biopsy specimens were obtained from women during a
natural menstrual cycle. All patients had menstrual cycles ranging in
length from 28 to 35 days and had not received exogenous hormonal
therapy for at least 2 months before the procedure. Women with systemic
diseases or sexually transmitted infections were excluded from the study.
The samples were examined by the same pathologists using the dating cri-
teria described by Noyes et al. (1975). Samples with evidence of endome-
tritis, endometrial hyperplasia and endometrial polyp were excluded from
the study. The phase of the natural menstrual cycle was conﬁrmed using
ultrasound and histological criteria and by measuring plasma luteinizing
hormone (LH) and progesterone. An LH urinary surge was also documen-
ted. Samples were taken around day 6 post ovulation (Cycle day 20–22).
Endometrial biopsies were obtained by Pipelle endometrial sampling or by
curettage (if the patients were having any surgical intervention in the form
of laparoscopy or hysteroscopy). Ethical approval was obtained from the
Local Research Ethics Committee at Abertawe Bro Morgannwg University
Trust, Singleton Hospital. Formal written consent was obtained from all
patients at the time of recruitment into the study.
The study groups consisted of infertile women with either endometrio-
sis, PCOS or unexplained infertility (UI). Endometriosis was diagnosed at
laparoscopy during investigation of pelvic pain or infertility. The diagnosis
was conﬁrmed by visual inspection of the pelvic organs or histological con-
ﬁrmation of endometriotic peritoneal lesions. PCOS was diagnosed based
on the Rotterdam criteria of ultrasound features and clinical and biochemi-
cal features of hyperandrogenism (Welt et al., 2006). The UI group
included women that were unable to conceive after 2 years with routine
investigations of fertility showing no abnormality. The control group was
formed by women with proven fertility and regular menstrual cycles (vol-
unteers or patients having surgery for other than fertility investigations).
The patients in the two groups were matched with regard to age, BMI
and smoking habits.
Antibodies
Puriﬁed rat anti-mouse peripheral lymph node addressin (PNAd) carbo-
hydrate epitope monoclonal antibody (MECA-79; BD Pharmingen) and
puriﬁed rat anti-Human Cutaneous Lymphocyte Antigen (CLA) mono-
clonal antibody (HECA-452; BD Pharmingen) were used to determine
the expression of L-selectin ligands. The MECA-79 antibody reacts with
sulfate-dependent carbohydrate epitopes of PNAd (Hemmerich et al.,
1994). The MECA-79 reactive antigen is closely associated with the carbo-
hydrate ligands for L-selectin (e.g. CD34, GlyCAM-1 and MadCAM-1)
(Toppila et al., 1999). The HECA-452 antibody reacts with CLA, a
carbohydrate domain shared by sLe
x and sialyl Lewis a (sLea) antigens
(Duijvestijn et al., 1988; Picker et al., 1991; Bos et al., 1993). A polyclonal
antibody against human GlcNAc6ST-2 was kindly provided by Professor
Steven D. Rosen (University of California, San Francisco, CA, USA).
Immunohistochemical detection
The samples were ﬁxed in 10% buffered formaldehyde for 24 h,
embedded in parafﬁn and 3–4 mm thick sections prepared on positively
charged slides before immunohistochemical (IHC) studies. The sections
were de-waxed with xylene and then descending grades of methanol
and distilled water. The tissue sections were incubated with puriﬁed rat
antihuman L-selectin ligand monoclonal antibodies at concentration
5 mg/ml (HECA-452; and MECA-79; BD Pharmingen). A positive
control section of tonsil and a negative (no antibody) control section of
endometrium tissue were used. For antigen retrieval, the slides were incu-
bated in CC1 buffer (Ventana) for an hour on heated plates at 1008Co na
Benchmark XT processor. Primary antibody incubation was for 32 min at
dilution 1:30 at 378C. Positive immunostaining was detected through inter-
action of avidin–biotin peroxidase complex with biotin conjugated sec-
ondary antibody using a Ventana I View DAB detection kit (Ventana
BioTek Solutions, Tucson, AZ, USA). The slides were subsequently
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DPX mountant to be examined under light microscopy. We used an
IHC scoring system, in which the same observers examined all the IHC
sections using a multi headed microscope (Lai et al., 2005). The observers
were blinded to the patients’ diagnosis, demographics and timing in the
cycle of endometrial biopsy.
The endometrial epithelium was assessed separately for the lumen and
glands and scored for intensity and distribution of staining. The intensity of
staining was scored from (0)-absent to (4)-strong. The distribution of
staining was deﬁned as follows: (0) ¼ absent, (1) ¼ ,30%, (2) ¼ 30 to
60%, (3) ¼ .60% and (4) ¼ 100% of the tissue surface stained.
Epithelial cells isolation and treatment
For isolation of epithelial cells, biopsy samples were collected in
Dulbecco’s modiﬁed eagle media (DMEM) containing antibiotic–antimy-
cotic solution. The tissues were washed twice in DMEM, ﬁnely minced,
and enzymatically digested with collagenase (134 U/ml) and deoxyribonu-
clease type I (156 U/ml) for 1 h at 378C. After centrifugation at 400   g
for 4 min, the pellet was resuspended in maintenance medium of DMEM,
10% dextran-coated charcoal-treated FBS (DCC-FBS), 2 mM L-glutamine
and 1% antibiotic–antimycotic solution (Invitrogen, UK). Epithelial cells
were separated from stromal cells on the basis of their differential attach-
ment to the culture plate. Total protein was isolated from conﬂuent
monolayers to analyze expression of MECA-79 and sulfotransferase
GlcNAc6ST-2.
Western blot analysis
Protein quantiﬁcation was by Bradford assay (Sigma, UK) and 20 mgo f
total protein was loaded and electrophoresed on a 10% sodium dodecyl
sulphate–polyacrylamide gel. Separated proteins were electrotransferred
onto activated polyvinylidene ﬂuoride membrane (Bio-Rad, UK) with
transfer buffer (50 mM Tris–HCl, 95 mM glycine and ethanol) for 1 h at
100 V. Membranes were blocked overnight with 5% bovine serum
albumin (BSA) diluted in 0.1% Tween-20-Tris buffered saline (TTBS,
blocking buffer) for MECA-79 detection or in 10% skimmed milk, in
0.1% TTBS for GlcNAc6ST-2 expression. Membranes were subsequently
incubated 1 h at 48C with rat anti-MECA-79 monoclonal antibody diluted
1/1000 in 5% BSA-TTBS or with rabbit anti-GlcNAc-GST2 antibody
diluted 1/1000 in 5% BSA-TTBS buffer. After washing ﬁve times with
TTBS, blots were incubated for 1 h at room temperature with the appro-
priated secondary antibody coupled to horseradish peroxidase. Between
the various incubation steps, the membranes were washed several times
with TTBS. The above samples were processed in parallel using a rabbit
anti-GAPDH antibody (Santa Cruz Biotech) and the appropriated second-
ary antibody in order to normalize the protein load on each well.
Protein bands were visualized using a ChemiDoc System Bio-Rad
Imager (Bio-Rad) and quantiﬁed by Quantity One
w Imaging software
(Bio-Rad) as a function of volume data (intensity/mm
2). The Volume Rec-
tangle Tool was used to measure the total signal intensity inside a
boundary drawn around the bands without overlapping adjacent bands.
Background was subtracted from each band volume by using local back-
ground subtraction. Intensities of bands acquired from each protein
extract were normalized against corresponding values for bands of the
house-keeping protein GAPDH and for comparative purposes expressed
as normalized volume. Results were expressed as percentage of normal-
ized volume with respect to the value of the fertile untreated group
(100%).
Statistical analysis
Data distributions were assessed for normality using the Ryan Joiner and
Kolmogorov Smirnov tests. A non-parametric Kruskal–Wallis test was
applied to determine signiﬁcant differences in the median between
groups (having data that was not normally distributed) for immunohisto-
chemistry scores and the percentage of normalized volume (immunoblot).
A Mann–Whitney U-test was then applied in a post hoc manner to deter-
mine signiﬁcant differences between speciﬁc group pairs for median scores
(immunohistochemistry) and the percentage of normalized volume (immu-
noblot) between, mainly fertile versus study groups. For data with a
normal distribution, an ANOVA test followed by an unpaired t-test was
used (Table I) to determine signiﬁcant differences between groups. The
test statistic and corresponding P-value were reported. All data analysis
was performed using Statistical Package for the Social Sciences version
10.0 (SPSS, Chicago, IL, USA).
Results
Clinical data and patients demographics
One hundred and thirty-one (131) patients were enrolled into this
study and endometrial samples were obtained from 117 patients in
the secretory phase of the cycle at LH þ 6. Samples were classiﬁed
into four groups: fertile (n ¼ 33), ovulatory PCOS (n ¼ 26), endo-
metriosis (n ¼ 25), UI (n ¼ 33). There were no statistically signiﬁ-
cant differences in the mean age (P ¼ 0.934) or BMI (P ¼ 0.669)
i nt h es a m p l e so rb e t w e e nt h ef e r t i l ea n di n f e r t i l ep a t i e n t s
(Table I).
IHC localization of MECA-79 in fertile
and infertile patients
Antibody reactivity localized at the luminal and glandular epithelium
was assessed by the intensity and distribution of the staining.
MECA-79 was localized to the epithelium, with no visible expression
in the stroma, and was observed predominantly at the cell membrane
with little cytoplasmic staining (Fig. 1).
MECA-79 distribution of staining in both the glandular and luminal
epithelium was signiﬁcantly different between groups (H ¼ 10.84,
.............................................................................................................................................................................................
Table I Comparison of patients’ demographics
Fertile Endometriosis PCOS UI
AGE 28.40+4.76 27.02+3.03 28.91+3.02 28.10+3.78
P ¼ 0.78 P ¼ 0.85 P ¼ 0.905
BMI (kg/m
2) 25.83+6.75 24.30+3.4 27.36+4.87 25.63+4.3
P ¼ 0.9 P ¼ 0.7 P ¼ 0.96
Note: Values are mean+standard deviation. UI, unexplained infertility.
L-selectin ligands in human endometrium 2769Figure 1 Expression of MECA-79 in glands and lumen in the secretory phase endometrium.
Secretory phase endometrium from fertile (33 patients), endometriosis (endom) (25 patients), PCOS (26 patients) and unexplained infertility (UI)
patients (33 patients) was analyzed for the expression of MECA-79 as described in Materials and Methods. In fertile women MECA-79 was strongly
expressed on the luminal epithelium and the glands compared with endometriosis (endom.), PCOS and UI . Magniﬁcations  400 (a, d, e and f),
 200 (b, c, g and h). Statistical analysis of the immunohistochemistry scores is showed in Fig. 3A.
2770 Margarit et al.Figure 2 Expression of HECA-452 in glands and lumen in the secretory phase endometrium.
Secretory phase endometrium from fertile (33 patients), endometriosis (endom) (25 patients), PCOS (26 patients) and unexplained infertility (UI)
patients (33 patients) was analyzed for the expression of HECA 452 as described in Materials and Methods. In endometriosis (endom.) and
PCOS the staining in the glands was signiﬁcantly stronger that in the fertile group. The UI group did not present any signiﬁcant difference in staining
of the glands compared with the fertile group (see Fig. 3B). Magniﬁcations  400 (b, h),  200 (a, c, d, e, f and g). Statistical analysis of the immu-
nohistochemistry scores is showed in Fig. 3B.
L-selectin ligands in human endometrium 2771Figure 3 MECA-79 and HECA-452 expression, intensity and distribution of staining in lumen and glands.
(A) and (B) Intensity and distribution scores for staining of HECA and MECA antibodies in endometrium of fertile and study groups are plotted. (C)
Cumulative scores for each antibody and groups are plotted. Values are median ( ) and inter-quartile range (box and whisker). The Kruskal–Wallis
test followed by a Mann–Whitney test was performed to determine ﬁrst statistical signiﬁcance between groups and secondly to compare speciﬁc
group pairs. *P   0.05 and **P   0.01 are considered signiﬁcant and are compared with fertile patients. Fertile (white box, n ¼ 33 patients),
PCOS (grey box, n ¼ 26 patients), UI (Dark grey box, n ¼ 33 patients), Endometriosis (Endom, hatched box, n ¼ 25 patients).
2772 Margarit et al.P ¼ 0.013 glands; H ¼ 19.60, P ¼ 0.000 lumen). In fact MECA-79 dis-
tribution of staining was signiﬁcantly greater in fertile patients than in
patients with PCOS (P ¼ 0.012 glands, and P ¼ 0.002 lumen), UI
(P ¼ 0.007 glands, and P ¼ 0.002 lumen) and endometriosis (P ¼
0.0007 glands, and P ¼ 0.000 lumen) (Figs 1 and 3A). Similarly
MECA-79 intensity of staining in the glandular and luminal epithelium
was signiﬁcantly different between groups (H ¼ 8.34, P ¼ 0.040
glands; H ¼ 24.75, P ¼ 0.000 lumen). When comparing the fertile
versus the infertile groups, MECA-79 staining was signiﬁcantly higher
in fertile patients than in patients with PCOS (P ¼ 0.0192 glands,
and P ¼ 0.001 lumen), UI (P ¼ 0.010 glands, and P ¼ 0.0002 lumen)
and endometriosis (P ¼ 0.010 glands, and P ¼ 0.000 lumen) (Figs 1
Figure 4 Relation between the staining with HECA-452 and MECA-79 in endometrium of fertile and infertile women.
Same regions were compared for staining with HECA-452 and MECA-79 for all groups. In all cases a reciprocal relation between staining with
MECA-79 and HECA-452 was observed regardless of the fertility status of the patients. Fertile (n ¼ 33 patients), PCOS (n ¼ 26 patients), UI
(n ¼ 33 patients), Endometriosis (Endom, n ¼ 25 patients). Magniﬁcations  200 (a, b, c, d and f)  100 (e, g and h).
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was preponderantly strong with a minimum variation from the median,
resulting in an inter-quartile range value of zero for individual and the
cumulative H-scores (Fig. 3A and C). There was no statistically signiﬁ-
cant difference in MECA-79 expression between PCOS, UI and endo-
metriosis study groups (Figs 1 and 3A).
IHC localization of HECA-452 in fertile and
infertile patients
A different pattern of staining was observed using HECA-452 antibody
compared with MECA-79. HECA-452 staining was found to be stron-
ger at the apical membrane of the cells than at the cytoplasmic level
(Fig. 2). In the glandular epithelium, HECA-452 intensity and distri-
bution of staining was signiﬁcantly different (H ¼ 11.84, P ¼ 0.008
intensity; H ¼ 10.43, P ¼ 0.015 distribution). There were signiﬁcant
increases in distribution (P ¼ 0.010) and intensity (P ¼ 0.007) of stain-
ing in the glands in the endometriosis compared with fertile patients
(Figs. 2 and 3B). Similarly, in the glandular epithelium, there was a sig-
niﬁcant increase in HECA-452 distribution (P ¼ 0.010) and intensity
(P ¼ 0.040) of staining in women with PCOS compared with fertile
patients (Figs. 2 and 3B). There was no signiﬁcant difference in the
intensity or distribution scores in the glands in women with UI com-
pared with fertiles (Figs. 2 and 3B).
In the luminal epithelium, no signiﬁcant differences were observed in
the intensity or distribution scores between the samples (H ¼ 0.71,
P ¼ 0.872 intensity; H ¼ 1.47, P ¼ 0.688 distribution).
Moreover, the scores for HECA-452 staining and distribution of
staining in the luminal epithelium were not signiﬁcantly different
when speciﬁc pair groups were compared (Figs. 2 and 3B). In endome-
triosis and PCOS, but not in UI patients, signiﬁcantly higher scores for
distribution (P ¼ 0.013 and P ¼ 0.004, respectively) and intensity (P ¼
0.02 and P ¼ 0.010, respectively) in the glands compared with the
lumen were observed.
Comparison between luminal and glandular
expression of L-selectin ligands
Comparative analysis of the cumulative scores (distribution plus inten-
sity scores) for MECA-79 indicated signiﬁcant differences between
groups (H ¼ 9.78, P ¼ 0.021 glands; H ¼ 21.58, P ¼ 0.000 lumen)
(Fig. 3C). However, no signiﬁcant differences were observed
between glands and lumen in each group. The cumulative scores
showed that MECA-79 was more strongly represented in the glands
and lumen of fertile patients than in PCOS (P ¼ 0.020 glands, P ¼
0.002 lumen), endometriosis (P ¼ 0.0123 glands, P ¼ 0.000 lumen)
and UI patients (P ¼ 0.005 glands, P ¼ 0.001 lumen) (Fig. 3C).
The cumulative scores indicated that HECA-452 was signiﬁcantly
different in the glands (H ¼ 12.73; P ¼ 0.005) between groups.
HECA-452 staining was more strongly represented in the glands in
PCOS (P ¼ 0.020) and endometriosis (P ¼ 0.002) than in fertile
patients (Fig. 3C). On the contrary, no signiﬁcant differences in the
cumulative scores were found between UI and fertile patients in the
glandular epithelium stained with HECA-452 antibody. There were
no statistically signiﬁcant differences between the cumulative scores
in the lumen (H ¼ 1.08, P ¼ 0.782) for HECA staining between
groups (Fig. 3C).
In the UI group, the cumulative score of staining for HECA-452 in
the glands was not signiﬁcantly higher compared with the lumen. In
the fertile group, there was no signiﬁcant difference in the cumulative
score between the glands and the lumen (Fig. 3C).
Reciprocal relation between expression of
MECA-79 and HECA-452
In individual cases an apparent reciprocal relationship between
MECA-79 and HECA-452 staining was observed for the fertile and
study groups (Fig. 4). When analyzing the fertile group versus any of
the study groups, a stronger staining for MECA-79 and lower staining
of HECA-452 was observed in fertile samples. The endometrium of
PCOS, UI and endometriosis groups showed a strong staining for
HECA-452 and a low staining for MECA-79 when compared with
the staining of fertile samples.
Analysis of MECA-79 and GlcNAc6ST-2
expression in endometrial epithelial cells
isolated from biopsies
The results for MECA-79 above suggested that sulfation of sLe
x deco-
rated L-selectin ligands may be impaired in infertile patients. To
explore this possibility MECA-79 epitopes were investigate in endo-
metrial cells in vitro and compared with expression of the sulfotransfer-
ase GlcNAc6ST-2 involved in MECA-79 epitope formation.
Figure 5 Expression of MECA-79 and sulfotransferase (GlcNAc-GST2) in epithelial cells isolated from endometrial biopsies.
(A) and (D) Protein extracts of epithelial cells isolated from biopsies obtained from fertile (F, n ¼ 6), endometriosis (Endom or Endo, n ¼ 6), PCOS
(n ¼ 6) and UI (n ¼ 6) patients were analyzed for the expression of MECA-79 (A) and GlcNAc-GST2 (D) as described in Materials and Methods.
Protein levels were normalized to GAPDH protein levels (A). In fertile (F) women MECA-79 as well as GlcNAc-GST2 was strongly expressed com-
pared with endometriosis (endom.), PCOS and UI. Representative blots are showed. (B) Densitometric analysis of each MECA-79 component was
performed using the Quantity One software (Bio-Rad). Values are band density normalized to GAPDH and are expressed as intensity per square
milimiters (INT*mm
2). Values are expressed as median ( ) and inter-quartile range (box and whisker). Fertile (white box), PCOS (grey box), UI
(Dark grey box), Endometriosis (Endom, hatched box). (C) Densitometric analysis of the area covering all MECA-79 components was perfomed
using the Quantity One software (Bio-Rad). Values are band density normalized to GAPDH and expressed as Intensity per square milimiters
(INT*mm
2). Values as expressed as median ( ) and inter-quartile range (box and whisker). Fertile (white box), PCOS (grey box), UI (Dark grey
box), Endometriosis (Endom, hatched box). (E) Densitometry analysis of the immunoblots GlcNAc-GST2 levels was performed using the Quantity
One software (Bio-Rad). Values obtained are expressed as band density compared with fertile patients and are expressed as percent. Values are
median ( ) and inter-quartile range (box and whisker). Fertile (white box), PCOS (grey box), UI (Dark grey box), Endometriosis (Endom,
hatched box). Statistical analysis of the samples (B, C and E) was performed using the Kruskal–Wallis test to determine signiﬁcance between
groups followed by a Mann–Whitney test to compare speciﬁc group pairs. *P   0.05 and **P   0.01 are considered signiﬁcant.
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from endometrial biopsies of fertile and infertile patients, and
MECA-79 expression detected by western blotting. Immunoreactivity
of MECA-79 was not restricted to a single band but was detected in
protein species of multiple molecular weights (Fig. 5A). This pattern
can be explained due to the expression of MECA-79 epitope in
several proteins in the cells such as mucins and CD34 (Genbacev
et al., 2003; Wang et al., 2008). A strong immunoreactivity was
found in four areas of the membrane previously described by Wang
and colleagues as component 1 (more than 200 kDa), 2
(200 kDa), 3 (120–170 kDa) and 4 (85 kDa). Therefore,
when analyzing MECA-79 expression, all bands represented in these
speciﬁc areas were quantiﬁed using a rectangle tool (Fig. 5B) as well
as the total band densities (sum of all components) (Fig. 5C)
between fertile and study groups.
Statistically signiﬁcant differences were observed after applying a
Kruskall–Wallis test to the data for each MECA-79 component
(H ¼ 16.89, P ¼ 0.001 component 1; H ¼ 11.85, P ¼ 0.008 com-
ponent 2; H ¼ 18.07, P ¼ 0.000 component 3; H ¼ 8.05, P ¼ 0.045
component 4). As shown in Fig. 5A and B, a statistically signiﬁcant
increase in component 1 and 2 of MECA-79 was observed in fertile
patients compared with endometriosis (P ¼ 0.0046 component 1;
P ¼ 0.004 component 2) and UI (P ¼ 0.0046 component 1; P ¼
0.041 component 2) patients. However, no signiﬁcant differences
were detected in components 1 and 2 between fertile and PCOS
(P ¼ 0.3734 component 1; P ¼ 0.3197 component 2) patients
(Fig. 5B). A signiﬁcant increase in component 3 and 4 was detected
in fertile patients compared with endometriosis (P ¼ 0.0051 com-
ponent 3; P ¼ 0.0289 component 4) and PCOS (P ¼ 0.0014 com-
ponent 3; P ¼ 0.0289 component 4) patients (Fig. 5B). No
signiﬁcant differences in components 3 and 4 were observed
between fertile and UI (P ¼ 0.1242 component 3; P ¼ 0.8082 com-
ponent 4) patients (Fig. 5B).
Furthermore statistically signiﬁcant differences were observed when
the total band density corresponding to MECA-79 expression was
compared between groups (H ¼ 13.03, P ¼ 0.005). Distinctively
MECA-79 total band density was signiﬁcantly lower in PCOS (P ¼
0.0304), endometriosis (P ¼ 0.030) and UI patients (P ¼ 0.050) than
in fertile patients (Fig. 5C). These results conﬁrmed the immunohisto-
chemistry ﬁndings of a reduction on MECA-79 expression in the infer-
tile groups compared with the fertile group (Figs. 1 and 5A).
The expression of GlcNAc6ST-2 was also signiﬁcantly different
between groups (H ¼ 10.11, P ¼ 0.018). Speciﬁcally expression of
GlcNAc6ST-2 was signiﬁcantly lower in samples from PCOS (P ¼
0.0112), UI (P ¼ 0.0347) and endometriosis (P ¼ 0.0369) cultures
compared with the fertile group (Fig. 5D and E).
Discussion
During the secretory phase of the menstrual cycle, the endometrium
completes its differentiation in preparation for implantation. Several
candidate molecules have been suggested to be involved in this
process and included those located in the luminal epithelium suggested
to be involved in embryo-endometrium apposition, adhesion and
attachment in the early stages of establishment of pregnancy
(McEver, 2002). Previous studies have investigated the role of
L-selectin ligands during the menstrual cycle and in early implantation
(Horne et al., 2002; Lai et al., 2005). L-selectin binds with low afﬁnity
sLe
x decorated ligands and sulfation of sLe
x -terminated glycans on the
6-position of GlcNAc activates the epitope as a high afﬁnity ligand for
L-selectin (Hemmerich et al., 1995; McEver, 2002). We have observed
an increase in HECA-452 epitopes in glandular epithelium of infertile
patients diagnosed with endometriosis and PCOS. Implantation in
these groups may be impaired because the abundance of low afﬁnity
ligands predominates over the high afﬁnity (sulfated) ligands.
Also reciprocal expression between MECA-79 and HECA-452 was
observed in some of the patients from all groups: fertile and infertile
women. Previous studies showed that in fertile patients abundance
of HECA-452 and MECA-79 epitopes increases from proliferative to
secretory phase (Lai et al., 2005). The results described here indicate
the expression of MECA-79 in fertile patients increases the most from
proliferative to secretory phase endometrium supporting the role of
sulfated carbohydrate ligands as the major ligands for L-selectin in
the uterus (Margarit and White, unpublished data and Fig. 3C).
Accordingly MECA-79 epitopes were expressed at a higher level in
fertile than in infertile patients diagnosed with PCOS, endometriosis or
UI, supporting a role of high afﬁnity interactions between L-selectins
and its ligands in implantation. Moreover, we have shown that the
expression pattern of sulfated O-glycosylated proteins recognized by
MECA-79 antibody also differs between these groups. Interestingly,
patients with endometriosis expressed a signiﬁcantly lower level of
all major components of MECA-79, whereas PCOS and UI patients
differ from fertile patients in lower (components 3 and 4) or higher
(components 1 and 2) molecular weight components, respectively.
A previous study demonstrated signiﬁcant reduction in the expression
of L-selectin ligands in a group of patients with repeat implantation
failure (subgroup of couples that suffer from UI) during estradiol/pro-
gesterone stimulated cycles (Foulk et al., 2007). Demonstration of
reduction in MECA-79 in patients with UI during normal, non-
stimulated cycles eliminates any potential effects of the ovulation
induction regimen.
Recent studies conﬁrmed that sLe
a, sLe
x and 6-sulfo sLe
x are
expressed in the epithelial cells but not the endothelial cells of
human endometrium (Eggens et al., 1989; Simon and Valbuena,
1999; Foulk et al., 2007). Optimal binding to L-selectin requires sulfa-
tion, sialylation and fucosylation of ligands. Analysis of GlyCAM-1 has
revealed two sulfation modiﬁcations (galactose [Gal]-6-sulfate and
N-acetylglucosamine [GlcNAc]-6-sulfate) of sLe
x (Tangemann et al.,
1999; Yamaguchi et al., 2006). In this study, we have shown that
expression of GlcNAc6ST-2 is decreased in infertile patients when
compared with fertile, which correlates with the decrease in
MECA-79 expression. This data is in agreement with that of Kao
and colleagues, who described down-regulation of GlcNAc-6ST
gene expression in endometriosis patients (Kao et al., 2003).
Further studies to investigate potential correlation between other
enzymes which modify L-selectin ligands will reveal if GlcNAc6ST-2
is uniquely down-regulated in association with endometrial infertility.
This is, to our knowledge, the ﬁrst report of signiﬁcant differences
between the expression of L-selectin ligands between fertile and infer-
tile women diagnosed with PCOS, endometriosis and UI in natural
cycles. This study highlights the potential importance of the relative
abundance of L-selectin ligands and in particular the speciﬁc
MECA-79 component, present in endometrial tissue. During the
secretory phase, expression of MECA-79 and HECA-452 in the
2776 Margarit et al.endometrium was related to the fertility status. Hence the pattern of
expression of L-selectin ligands may be a factor that contributes to
endometrium-related infertility through control of high and low afﬁnity
interactions with embryo trophoblast.
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